Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD)
Public ClinicalTrials.gov record NCT00821093. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12 Week Treatment, Multi-center, Randomized, Parallel Group, Double Blind, Double Dummy Study to Assess the Superiority of Indacaterol (150 µg o.d.) Via a SDDPI in Patients With Moderate to Severe COPD, Using Salmeterol (50 µg b.i.d.) as an Active Comparator Delivered Via a DISKUS Inhaler
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study compared the safety and efficacy of indacaterol 150 µg taken once daily (o.d.) versus salmeterol 50 µg taken twice daily (b.i.d) in patients 40 years old or older with chronic obstructive pulmonary disease.
Study identification
- NCT ID
- NCT00821093
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,123 participants
Conditions and interventions
Conditions
Interventions
- Indacaterol 150 µg Drug
- Salmeterol 50 µg Drug
- Placebo to indacaterol Drug
- Placebo to salmeterol Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2009 (Type not available)
- Primary completion
- Oct 2009 (Actual)
- Completion
- Oct 2009 (Actual)
- Last update posted
- Aug 18, 2011
2009
United States locations
- U.S. sites
- 74
- U.S. states
- 31
- U.S. cities
- 72
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigator Site | Anniston | Alabama | 36207-5710 | — |
| Novartis Investigator Site | Fairhope | Alabama | 36532 | — |
| Novartis Investigator Site | Jasper | Alabama | 35501 | — |
| Novartis Investigator Site | Mobile | Alabama | 36604 | — |
| Novartis Investigator Site | Glendale | Arizona | 85306 | — |
| Novartis Investigator Site | Phoenix | Arizona | 85006 | — |
| Novartis Investigator Site | Buena Park | California | 90620 | — |
| Novartis Investigator Site | Encinitas | California | 92024 | — |
| Novartis Investigator Site | Fullerton | California | 92535 | — |
| Novartis Investigator Site | Rancho Mirage | California | 92270 | — |
| Novartis Investigator Site | Riverside | California | 92506 | — |
| Novartis Investigator Site | San Diego | California | 92120 | — |
| Novartis Investigator Site | Torrance | California | 90505 | — |
| Novartis Investigator Site | Walnut Creek | California | 94598 | — |
| Novartis Investigator Site | Fort Collins | Colorado | 80528 | — |
| Novartis Investigative Site | Wheat Ridge | Colorado | 80033 | — |
| Novartis Investigative Site | Stamford | Connecticut | 06902 | — |
| Novartis Investigative Site | Newark | Delaware | 19713 | — |
| Novartis Investigative Center | Clearwater | Florida | 33765 | — |
| Novartis Investigative Site | Pensacola | Florida | 32504 | — |
| Novartis Investigative Site | Pensacola | Florida | 32514 | — |
| Novartis Investigative Site | South Miami | Florida | 33143 | — |
| Novartis Investigative Site | Tamarac | Florida | 33321 | — |
| Novartis Investigative Site | Tampa | Florida | 33603 | — |
| Novartis Investigative Site | Tampa | Florida | 33613 | — |
| Novartis Investigative Site | Marietta | Georgia | 30060 | — |
| Novartis Investigator Site | Normal | Illinois | 61761 | — |
| Novartis Investigator Site | River Forest | Illinois | 60305 | — |
| Novartis Investigator Site | Skokie | Illinois | 60076 | — |
| Novartis Investigator Site | Olathe | Kansas | 66061 | — |
| Novartis Investigator Site | Wichita | Kansas | 67207 | — |
| Novartis Investigator Site | Madisonville | Kentucky | 42431 | — |
| Novartis Investigator Site | New Orleans | Louisiana | 70115 | — |
| Novartis Investigator Site | Opelousas | Louisiana | 70570 | — |
| Novartis Investigative Site | Baltimore | Maryland | 21236 | — |
| Novartis Investigator Site | Ann Arbor | Michigan | 48106 | — |
| Novartis Investigator Site | Livonia | Michigan | 48152 | — |
| Novartis Investigator Site | Minneapolis | Minnesota | 55407 | — |
| Novartis Investigator Site | Saint Charles | Missouri | 63301-2847 | — |
| Novartis Investigator Site | St Louis | Missouri | 63141 | — |
| Novartis Investigator Site | Lincoln | Nebraska | 68510 | — |
| Novartis Investigator Site | Omaha | Nebraska | 68134 | — |
| Novartis Investigator Site | Henderson | Nevada | 89014 | — |
| Novartis Investigative Site | Reno | Nevada | 89502 | — |
| Novartis Investigative Site | Cherry Hill | New Jersey | 08003 | — |
| Novartis Investigative Site | Summit | New Jersey | 07901 | — |
| Novartis Investigator Site | Albuquerque | New Mexico | 87108 | — |
| Novartis Investigative Site | Larchmont | New York | 10538 | — |
| Novartis Investigative Site | Charlotte | North Carolina | 28207 | — |
| Novartis Investigative Site | Hickory | North Carolina | 28601 | — |
| Novartis Investigative Site | Raleigh | North Carolina | 27607 | — |
| Novartis Investigative Site | Shelby | North Carolina | 28150 | — |
| Novartis Investigator Site | Cincinnati | Ohio | 45245 | — |
| Novartis Investigator Site | Columbus | Ohio | 42313 | — |
| Novartis Investigator Site | Willoughby Hills | Ohio | 44094 | — |
| Novartis Investigator Site | Tulsa | Oklahoma | 74135-2920 | — |
| Novartis Investigator Site | Eugene | Oregon | 97404 | — |
| Novartis Investigator Site | Medford | Oregon | 97504-8741 | — |
| Novartis Investigator Site | Portland | Oregon | 97213 | — |
| Novartis Investigative Site | Erie | Pennsylvania | 16506 | — |
| Novartis Investigative Site | Charleston | South Carolina | 29412 | — |
| Novartis Investigative Site | Greenville | South Carolina | 29615 | — |
| Novartis Investigative Site | North Charleston | South Carolina | 29406-7108 | — |
| Novartis Investigative site | Spartanburg | South Carolina | 29303 | — |
| Novartis Investigative Site | Union | South Carolina | 29379 | — |
| Novartis Investigator Site | El Paso | Texas | 79903 | — |
| Novartis Investigator Site | Fort Worth | Texas | 76104 | — |
| Novartis Investigator Site | Houston | Texas | 77024 | — |
| Novartis Investigator Site | San Antonio | Texas | 78212 | — |
| Novartis Investigative Site | Abingdon | Virginia | 24210 | — |
| Novartis Investigative Site | Richmond | Virginia | 23229 | — |
| Novartis Investigator Site | Spokane | Washington | 99204 | — |
| Novartis Investigator Site | Tacoma | Washington | 98405-4266 | — |
| Novartis Investigator Site | Milwaukee | Wisconsin | 53209-0996 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00821093, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2011 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00821093 live on ClinicalTrials.gov.